My colleague Pranay Lal, who coordinates our health and environment unit, got a call from
a reader of this newsletter. The doctor was interested in finding out if the advertisement
released by BPL showing a pregnant woman with a cellphone pressed to her pregnant stomach
had any medical implications. What is the impact of cellphones on human bodies?
This is a hotly debated issue in scientific circles and it is clear that the jury is still
out of the final decision. On the one hand studies many industry sponsored
show that there is little evidence of a causal relationship between cancer and radiation
from cellphones; other studies suggest that the link exists and is deadly. I dont
intend to discuss the merits of this specific case with you. Whatever the final verdict on
the electromagnetic pollution and its toxicity, I will discuss two of what I believe are
related and critical issues.
First, is the issue of the role of private funding for public research. There is
growing concern about the need to promote transparency in funding of research that affects
public policy. The growing influence of the drug industry funding on academic research and
the growing number of cases where data are withheld, spun or otherwise manipulated when
results are disadvantageous to the funder is now a frequent and frightening phenomenon.
A recent study published in the Journal of American Medical Association (JAMA), reveals
that published statistics on new drugs are a scam like Enron. Washington Post wrote
how a pharmaceutical company, Pharmacia Corporation, funded a study to show that Celebrex,
a medicine, works better than cheap alternatives such as Ibuprofen.The study collected 12
months of data,
Which showed no major advantage. But the authors selectively
published the first six months of results, claiming that Celebrex had fewer side effects
and this trick made patients spend US $3 billion. Rigging data is very profitable.
This is hardly surprising. Science is hard money and in politics the stakes are high.
Starting from tobacco research to drug trials and now the extremely contentious health and
safety issues concerning genetically modified organism (GMOs) and cellphones, it is
important to ensure that public policy is not allowed to get manipulated or be confusing.
The role of independent and credible research, therefore, becomes all the more important
especially in an increasingly technocratic society.
What is worrying is that while industry has always supported some research, the balance
of power in the collaboration between companies and academic institutions is shifting.
Corporate research budgets are rising much faster than government and charitable
foundations, making these institutions more dependent on industry sponsorship. Academics
are facing increasing competition from the fast growing consultancy research sector, which
is less constrained by traditions of independence and objectivity.
The second issue is that we have to exercise the precautionary principle in making
decisions. Science often cannot give us a precise assessment of the problem. It is because
of this that we need to often apply the precautionary principle so that even if the final
risk assessment is still not concluded and the final scientific certainty is not known, we
know enough to say that there could be a possible risk. Caution and precaution is what is
needed. It is important because the stakes are too high. After all we are dealing with
life here. Not money. Not politics.
Sunita Narain
Director